| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.35 | 0.04 |